ConductScience.org, home

Paper46840

Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

Budzko DB and 2 others. Infect Immun, 1975. Cited by 105 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Papers, record 46840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46840

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.
PubMed
Journal
Infect Immun
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.82
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Budzko DBD B
2Pizzimenti MCM C
3Kierszenbaum FF

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chagas DiseaseMajor topic
Complement System ProteinsMajor topic
Trypanosoma cruziMajor topic
TrypanosomiasisMajor topic
Animals
Endotoxins
Escherichia coli
Humans
Immune Sera
Lectins
Male
Mice
Snakes
Venoms
gamma-Globulins

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
34213449The immunology of experimental Chagas' disease. I. Preparation of Trypanosoma cruzi antigens and humoral antibody response to there antigens.J Immunol1974https://conductscience.org/library/papers/4213449PubMed
44361979Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.J Immunol1974https://conductscience.org/library/papers/4361979PubMed
54564786Role of complement in immune lysis of Trypanosoma cruzi.Infect Immun1972https://conductscience.org/library/papers/4564786PubMed
64627510C3 shunt activation in human serum chelated with EGTA.J Immunol1972https://conductscience.org/library/papers/4627510PubMed
74629840The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi.J Protozool1972https://conductscience.org/library/papers/4629840PubMed
84983548[Sensitivity of serological tests in the diagnosis of Chagas' disease].Bol Chil Parasitol1969https://conductscience.org/library/papers/4983548PubMed
95120401Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.J Immunol1971https://conductscience.org/library/papers/5120401PubMed

Download CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
28919885Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.Front Microbiol2017https://conductscience.org/library/papers/28919885PubMed
26745156Genetically Determined MBL Deficiency Is Associated with Protection against Chronic Cardiomyopathy in Chagas Disease.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/26745156PubMed
20625554Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.PLoS Negl Trop Dis2010https://conductscience.org/library/papers/20625554PubMed
20037731Improved method for in vitro secondary amastigogenesis of Trypanosoma cruzi: morphometrical and molecular analysis of intermediate developmental forms.J Biomed Biotechnol2010https://conductscience.org/library/papers/20037731PubMed
10194457Chagas' disease and the autoimmunity hypothesis.Clin Microbiol Rev1999https://conductscience.org/library/papers/10194457PubMed
9596703Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.Infect Immun1998https://conductscience.org/library/papers/9596703PubMed
7873124Trypanosoma cruzi infection in rats induced early lesion of the heart noradrenergic nerve terminals by a complement-independent mechanism.J Neural Transm Gen Sect1994https://conductscience.org/library/papers/7873124PubMed
6797951Induction of the acute-phase protein serum amyloid P in experimental Chagas' disease.Infect Immun1982https://conductscience.org/library/papers/6797951PubMed
6793386Immune T cells control Trypanosoma cruzi infections.Experientia1981https://conductscience.org/library/papers/6793386PubMed
6772558Experimental Chagas' disease in complement-deficient mice and guinea pigs.Infect Immun1980https://conductscience.org/library/papers/6772558PubMed
6772557Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells.Infect Immun1980https://conductscience.org/library/papers/6772557PubMed
6698607Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.Infect Immun1984https://conductscience.org/library/papers/6698607PubMed
6454138Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6454138PubMed
6421519Isotype of lytic antibodies in serum of Chagas' disease patients.Clin Exp Immunol1984https://conductscience.org/library/papers/6421519PubMed
3926649Trypanolytic activity, agglutinins, and opsonins in sera from animals refractory to Trypanosoma lewisi.Infect Immun1985https://conductscience.org/library/papers/3926649PubMed
3910312Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.Clin Exp Immunol1985https://conductscience.org/library/papers/3910312PubMed
3653986Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.Infect Immun1987https://conductscience.org/library/papers/3653986PubMed
3143107A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection.Parasitol Res1988https://conductscience.org/library/papers/3143107PubMed
2663722Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.Infect Immun1989https://conductscience.org/library/papers/2663722PubMed
2104596Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.Infect Immun1990https://conductscience.org/library/papers/2104596PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/46840

GET https://conductscience.org/api/papers/v1/46840/cited_by?page=2